JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Support: [email protected]

Track Your Order

FLT3

A4145 TG101209

Summary: JAK2/3 inhibitor

≥25.5 mg/mL
A4123 KW 2449

Target: Aurora Kinases|FLT3|Bcr-Abl

Summary: Multikinase inhibitor

insoluble in EtOH; insoluble in H2O; ≥16.6 mg/mL
A3847 SU5416
7 Citation

Target: VEGFR

Summary: VEGFR2 inhibitor

insoluble in EtOH; insoluble in H2O; ≥11.9 mg/mL
A3818 Silvestrol

Summary: Antineoplastic

Soluble in DMSO
A3794 SB1317

Summary: CDK,JAK and FLT inhibitor

insoluble in H2O; ≥44.87 mg/mL
A3194 AST 487
1 Citation

Target: RET

Summary: RET kinase inhibitor

≥26.5 mg/mL
A2977 Cabozantinib (XL184, BMS-907351)

Summary: VEGFR2/Met/Ret/Kit/FLT//AXL inhibitor

≥25.08 mg/mL
A2949 Linifanib (ABT-869)

Target: VEGFR|PDGFR

Summary: VEGFR/PDGFR inhibitor

insoluble in H2O; insoluble in EtOH; ≥18.75 mg/mL
A2323 TCS 359

Summary: Potent FLT3 inhibitor

insoluble in EtOH; insoluble in H2O; ≥9 mg/mL